UNLOCKD Inc. (OTCID: BFCH), doing business as UNLOCKD, reported encouraging early operating results for its recently acquired subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, highlighting a 76% month-over-month revenue increase. Preliminary May 2026 revenue reached approximately $22,344, up from $12,670 in April, according to a press release from the company. The acquisition closed in mid-May, meaning the reported revenue reflects only a partial month under UNLOCKD ownership.
Additionally, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of about $29,411 under wholesale pricing terms. All financial figures are preliminary, unaudited, and subject to adjustment.
John P. Gorst, Chief Executive Officer of UNLOCKD, stated, "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing. The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition." He emphasized a focus on disciplined execution, strengthening operations, expanding distribution, and creating long-term shareholder value.
Ancient Extracts offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha, shilajit, and wellness consumer goods under the brand philosophy "Ancient Remedies for Modern Life." The company believes it is well positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Management views Ancient Extracts as a capital-efficient operating foundation to pursue further commercialization, strategic partnerships, product innovation, and long-term expansion. Dr. Jordan P. Balencic, Chairman and Chief Science Officer, commented, "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth." He added that the objective is straightforward: grow revenue, expand distribution, strengthen the portfolio of wellness assets, and execute with discipline.
Separately, UNLOCKD announced that its UNLOCKD Technologies division has begun preliminary planning for future consumer health technology opportunities. Management has initiated early-stage evaluation of point-of-care testing concepts and engaged in preliminary discussions with developers, suppliers, and potential strategic partners. These initiatives remain in conceptual and planning stages, and the company expects any future technology development to follow a milestone-driven approach with dedicated financing.
The news highlights UNLOCKD's transition toward a revenue-generating wellness platform, leveraging acquisitions to build scale. For leaders in business and technology, this signals the potential for growth in the functional wellness market and the importance of disciplined integration and commercialization strategies. As the company progresses, its ability to sustain momentum and execute on partnerships will be key to long-term value creation.
For more information, visit www.unlockdinc.com and follow @BFCHco on X.
